Skip to content
Buy This GLP
← Research
Evidence

Is a GLP-1 Better Than Metformin for PCOS? What the Trials Found

Adding a GLP-1 drug to metformin modestly lowered weight in small trials. Direct comparisons gave mixed results.

Editorial profile: Wesley JenkinsBuy This GLP Editorial Team4 min read
Eleven randomized trials in PCOS: what they looked atBMImeasured, low certaintyLDL and triglyceridesmeasured, no differenceglucose and insulininsufficient evidencehirsutisminsufficient evidencemenstrual regularityinsufficient evidencequality of lifeno studiesmental healthno studiescost-effectivenessno studiesResults from one 2026 evidence review.

The broader GLP-1 research in PCOS includes studies with different comparison treatments. Replacing metformin and adding to it answer different questions.

Direct comparisons with metformin

A 2019 review of eight randomized trials reported better BMI and insulin resistance results with GLP-1 drugs than with metformin [2]. The authors rated the evidence moderate to low quality. The reported BMI effect was a standardized measure.

The review supporting the international guideline could pool only exenatide against metformin [3]. It found no clear difference in weight or fasting insulin. Fasting glucose results slightly favored metformin, with very low certainty.

Adding a GLP-1 to metformin

In a 2025 review, adding a GLP-1 drug was associated with 1.37 kg greater weight loss than metformin alone (95% CI 0.67 to 2.07 kg) [4]. The trials also found a smaller waist circumference and lower fasting glucose with the combination.

A 2026 review included 11 trials and several different comparators [1]. Adding a GLP-1 drug lowered BMI by an estimated 1.38 kg/m², with low certainty. Evidence was insufficient for conclusions about menstrual regularity or excess hair growth.

If pregnancy is a near-term goal, the specific drug's pregnancy guidance can affect the treatment plan. The 2026 review found no included trials assessing quality of life, mental health or cost-effectiveness.

Which treatment fits depends on the symptom or health risk being treated. The weight data alone do not establish which medication is better for PCOS overall.

Frequently asked

Is a GLP-1 better than metformin for PCOS?
Some small trials found better weight and insulin resistance outcomes. A guideline evidence review found no clear weight difference between exenatide and metformin.
How much difference did adding a GLP-1 make to weight?
One pooled estimate was 1.37 kg more weight loss than with metformin alone. Longer-term effects remain uncertain.
Do GLP-1 drugs help irregular periods or excess hair growth in PCOS?
A 2026 review found insufficient evidence to draw conclusions on either outcome.

Sources

  1. [1] Forslund M, et al. (2026). GLP-1 receptor agonist treatment in women with polycystic ovary syndrome-a systematic review and meta-analysis European Journal of Endocrinology. PMID 41701618
  2. [2] Han Y, Li Y, He B (2019). GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis Reproductive BioMedicine Online. PMID 31229399
  3. [3] Goldberg A, et al. (2024). Anti-obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta-analysis to inform the 2023 international evidence-based guideline Obesity Reviews. PMID 38355887
  4. [4] Zhao Y, et al. (2025). Comparison of GLP-1 Receptor Agonists Combined with Metformin Versus Metformin Alone in the Management of PCOS: A Comprehensive Meta-Analysis Reproductive Sciences. PMID 39881036

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Evidence